Cadre Holdings, Inc. (CDRE)
NYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Manufacturing · CIK 1860543 · fiscal year ends in Dec
Closing price $31.11 on 29 Oct 2026; 52-week range $24.55 to $46.07.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $685.6M
- Revenue growth
- 19.7%
- Net income, last twelve months
- $36.1M
- Earnings per share
- $0.85
- Gross margin
- 41.8%
- Operating margin
- 10.1%
- Net margin
- 5.3%
- Free cash flow
- $78.1M
- Return on equity
- 10.4%
- Market value
- $1.3B
- Price to earnings
- 36.6x
- Dividend yield
- 1.3%
- Cash
- $54.0M
- Debt
- $374.3M
- Debt to equity
- 1.08
- Shares outstanding
- 42.8M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $610.3M | $67.4M | $44.1M | $1.02 | $56.8M | 10-K filed 10 Mar 2026 |
| FY2024 | 31 Dec 2024 | $567.6M | $66.8M | $36.1M | $0.90 | $26.1M | 10-K filed 11 Mar 2025 |
| FY2023 | 31 Dec 2023 | $482.5M | $56.5M | $38.6M | $1.02 | $66.5M | 10-K filed 12 Mar 2024 |
| FY2022 | 31 Dec 2022 | $457.8M | $16.7M | $5.8M | $0.16 | $41.9M | 10-K filed 15 Mar 2023 |
| FY2021 | 31 Dec 2021 | $427.3M | $51.7M | $12.7M | $0.44 | $37.3M | 10-K filed 11 Mar 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $207.1M | $11.4M | $0.26 |
| Q1 FY2026 | 31 Mar 2026 | $155.4M | $2.0M | $0.05 |
| Q4 FY2025 | 31 Dec 2025 | $167.2M | $11.7M | $0.27 |
| Q3 FY2025 | 30 Sep 2025 | $155.9M | $10.9M | $0.27 |
| Q2 FY2025 | 30 Jun 2025 | $157.1M | $12.2M | $0.30 |
| Q1 FY2025 | 31 Mar 2025 | $130.1M | $9.2M | $0.23 |
| Q4 FY2024 | 31 Dec 2024 | $176.0M | $13.0M | $0.32 |
| Q3 FY2024 | 30 Sep 2024 | $109.4M | $3.7M | $0.09 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By region, FY2025
| Segment | Revenue | Share |
|---|---|---|
| United States | $461.4M | 75.6% |
| International | $148.9M | 24.4% |
Company events
The newest 8-K filings of 49 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 7 Aug 2026 | 8-K/A | Results | 2.02, 9.01 |
| 5 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 29 Jul 2026 | 8-K | Material agreement, New debt | 1.01, 2.03, 9.01 |
| 3 Jun 2026 | 8-K | Leadership change, Shareholder vote | 5.02, 5.07 |
| 11 May 2026 | 8-K | Results | 2.02, 9.01 |
| 10 Mar 2026 | 8-K | Results | 2.02, 9.01 |
| 2 Feb 2026 | 8-K/A | Material agreement | 1.01, 9.01 |
| 4 Nov 2025 | 8-K | Results | 2.02, 9.01 |
| 3 Nov 2025 | 8-K | Material agreement | 1.01, 9.01 |
| 29 Oct 2025 | 8-K | Investor update | 7.01, 9.01 |
| 8 Oct 2025 | 8-K | Investor update | 7.01, 9.01 |
| 5 Aug 2025 | 8-K | Results | 2.02, 9.01 |
Every filing
The newest filings with the SEC of 146 held.
| Filed | Form | Period |
|---|---|---|
| 7 Aug 2026 | EFFECT | – |
| 7 Aug 2026 | 8-K/A | 5 Aug 2026 |
| 5 Aug 2026 | S-4/A | – |
| 5 Aug 2026 | 10-Q | 30 Jun 2026 |
| 5 Aug 2026 | 8-K | 5 Aug 2026 |
| 29 Jul 2026 | 8-K | 23 Jul 2026 |
| 3 Jun 2026 | 8-K | 29 May 2026 |
| 29 May 2026 | SD | – |
| 14 May 2026 | DEFA14A | – |
| 11 May 2026 | 10-Q | 31 Mar 2026 |
| 11 May 2026 | 8-K | 11 May 2026 |
| 24 Apr 2026 | ARS | 31 Dec 2025 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 25 Aug 2026 | Kanders Warren B, CEO AND CHAIRMAN | Sale outside a trading plan | 55,345 | $31.54 | $1.7M | 9,461,694 | 26 Aug 2026 |
| 25 Aug 2026 | Kanders Warren B, CEO AND CHAIRMAN | Sale outside a trading plan | 44,655 | $32.28 | $1.4M | 9,417,039 | 26 Aug 2026 |
| 24 Aug 2026 | Kanders Warren B, CEO AND CHAIRMAN | Sale outside a trading plan | 65,431 | $33.20 | $2.2M | 9,551,608 | 26 Aug 2026 |
| 24 Aug 2026 | Kanders Warren B, CEO AND CHAIRMAN | Sale outside a trading plan | 34,569 | $33.65 | $1.2M | 9,517,039 | 26 Aug 2026 |
| 17 Aug 2026 | Williams Brad, PRESIDENT | Sale outside a trading plan | 104 | $34.34 | $3.6K | 153,719 | 19 Aug 2026 |
| 17 Aug 2026 | Williams Brad, PRESIDENT | Sale outside a trading plan | 88,638 | $33.24 | $2.9M | 65,081 | 19 Aug 2026 |
| 22 Jun 2026 | Kanders Warren B, CEO AND CHAIRMAN | Sale outside a trading plan | 50,000 | $27.43 | $1.4M | 9,617,039 | 23 Jun 2026 |
| 18 Jun 2026 | Kanders Warren B, CEO AND CHAIRMAN | Sale outside a trading plan | 25,000 | $27.86 | $696.5K | 9,667,039 | 23 Jun 2026 |
| 17 Jun 2026 | Kanders Warren B, CEO AND CHAIRMAN | Sale outside a trading plan | 25,000 | $28.68 | $717.0K | 9,692,039 | 17 Jun 2026 |
| 16 Jun 2026 | Kanders Warren B, CEO AND CHAIRMAN | Sale outside a trading plan | 100,000 | $28.19 | $2.8M | 9,717,039 | 17 Jun 2026 |
| 15 Jun 2026 | Kanders Warren B, CEO AND CHAIRMAN | Sale outside a trading plan | 100,000 | $30.03 | $3.0M | 9,817,039 | 17 Jun 2026 |
| 23 Mar 2026 | Kanders Warren B, CEO AND CHAIRMAN | Sale outside a trading plan | 100,000 | $31.93 | $3.2M | 9,917,039 | 24 Mar 2026 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 25 Aug 2026 | Warren B. Kanders, Officer, Director, 10% Shareholder | 100,000 | $3.2M | 25 Aug 2026 |
| 24 Aug 2026 | Warren B. Kanders, Officer, Director, 10% Shareholder | 100,000 | $3.3M | 24 Aug 2026 |
| 17 Aug 2026 | Brad Williams, Officer | 88,742 | $3.0M | 17 Aug 2026 |
| 15 Jun 2026 | Warren B. Kanders, Officer, Director, 10% Stockholder | 300,000 | $9.3M | 15 Jun 2026 |
| 20 Mar 2026 | Warren B Kanders, Officer, Director, 10% Stockholder | 200,000 | $6.3M | 20 Mar 2026 |
| 12 Dec 2025 | Blaine Browers, Officer | 20,435 | $899.1K | 12 Dec 2025 |
| 10 Dec 2025 | Brad Williams, Officer | 24,000 | $1.0M | 10 Dec 2025 |
| 17 Nov 2025 | Warren B. Kanders, Officer, Director, 10% Stockholder | 1,343,941 | $56.6M | 17 Nov 2025 |
| 13 Nov 2025 | Brad Williams, Officer | 27,370 | $1.2M | 13 Nov 2025 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 30 Sep 2026 | Warren B. Kanders | 13D amended | 25.8% | 11.1M |
| 6 Aug 2026 | FMR LLC | 13G amended | 5.8% | 2.5M |
| 18 Jun 2026 | Warren B. Kanders | 13D amended | 26.4% | 11.4M |
| 14 May 2026 | Capital International Investors | 13G amended | 3% | 1.3M |
| 6 May 2026 | FMR LLC | 13G amended | 7.8% | 3.3M |
| 12 Feb 2026 | REINHART PARTNERS, LLC. | 13G | 5.34% | 2.2M |
| 5 Feb 2026 | FMR LLC | 13G amended | 9.3% | 3.8M |
| 19 Nov 2025 | Warren B. Kanders | 13D amended | 27.7% | 11.7M |
| 14 Nov 2025 | Warren B. Kanders | 13D | 30.9% | 13.0M |
Trades by members of the House
From each member's periodic transaction report.
| Traded | Member | Type | Amount | Disclosed |
|---|---|---|---|---|
| 30 Jun 2026 | Gilbert Cisneros (CA31) | Purchase | $1,001 - $15,000 | 2 Jul 2026 |
| 16 Mar 2026 | Gilbert Cisneros (CA31) | Purchase | $1,001 - $15,000 | 7 Apr 2026 |
| 11 Jun 2025 | Gilbert Cisneros (CA31) | Purchase | $1,001 - $15,000 | 10 Jul 2025 |
| 17 Apr 2025 | Josh Gottheimer (NJ05) | Sale | $1,001 - $15,000 | 14 May 2025 |
| 27 Jan 2025 | Josh Gottheimer (NJ05) | Purchase | $1,001 - $15,000 | 10 Feb 2025 |
| 27 Dec 2024 | Josh Gottheimer (NJ05) | Sale | $1,001 - $15,000 | 14 Jan 2025 |
| 6 Dec 2024 | Josh Gottheimer (NJ05) | Purchase | $1,001 - $15,000 | 14 Jan 2025 |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 1.9M | -4.68% | 3.21 |
| 30 Sep 2026 | 2.0M | -12.32% | 3.27 |
| 15 Sep 2026 | 2.3M | +4.31% | 6.35 |
| 31 Aug 2026 | 2.2M | -3.98% | 7.16 |
| 14 Aug 2026 | 2.3M | -27.94% | 4.75 |
| 31 Jul 2026 | 3.1M | +19.78% | 8.71 |
| 15 Jul 2026 | 2.6M | +11.78% | 10.04 |
| 30 Jun 2026 | 2.3M | +18.94% | 3.63 |
Funds that hold it
From each fund's latest Form 13F.
183 funds held it at 30 Jun 2026: 88 added and 42 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 2,936,878 | $83.7M | +310,495 |
| Greenhouse Funds LLLP | 2,868,664 | $81.8M | +286 |
| Reinhart Partners, LLC. | 2,738,373 | $78.1M | +500,476 |
| FMR LLC | 2,475,623 | $70.6M | -843,573 |
| State Street Corp. | 1,949,734 | $55.6M | +553,411 |
| Capital International Investors | 1,622,466 | $46.3M | +361,660 |
| Vanguard Capital Management LLC | 1,324,254 | $37.8M | +76,805 |
| GW&K Investment Management, LLC | 1,274,371 | $36.3M | +227,195 |
| Capital World Investors | 1,205,237 | $34.4M | +32,880 |
| Wynnefield Capital Inc. | 1,205,000 | $34.4M | +55,000 |
Peers
Companies in the same industry.
- Intuitive Surgical Inc. (ISRG): revenue $11.6B, market value $155.5B
- Edwards Lifesciences Corp. (EW): revenue $6.5B, market value $54.5B
- Steris plc (STE): revenue $6.0B, market value $22.6B
- Zimmer Biomet Holdings, Inc. (ZBH): revenue $8.5B, market value $18.6B
- Smith & Nephew plc (SNN): revenue $6.2B, market value $13.3B
- Align Technology Inc. (ALGN): revenue $4.1B, market value $11.0B
- MSA Safety Inc. (MSA): revenue $1.9B, market value $6.9B
- Establishment Labs Holdings Inc. (ESTA): revenue $245.8M, market value $2.0B
- Enovis Corp. (ENOV): revenue $2.3B, market value $1.3B
- Anteris Technologies Global Corp. (AVR): revenue $2.2M, market value $624.4M